Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,973
datasets available to search
ShareScore release 0.9.0
Dataset results
1,973 results for “T cell receptor”
Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Ca
ClinicalTrials.gov study NCT05098210. IPD Sharing: NO. Countries: 1. Publications: 0.
Testing the Combination of MLN0128 (TAK-228) and AZD9291 in Advanced EGFR (Epidermal Growth Factor Receptor) Mutation Positive Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT02503722. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy
ClinicalTrials.gov study NCT06055439. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase 1b/2 Trial of Ipilimumab, Nivolumab, and Ciforadenant (Adenosine A2a Receptor Antagonist) in First-line Advanced Renal Cell Carcinoma.
ClinicalTrials.gov study NCT05501054. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Chimeric Antigen Receptor (CAR) T Cells With a Chlorotoxin Tumor-Targeting Domain for the Treatment of MMP2+ Recurrent or Progressive Glioblastoma
ClinicalTrials.gov study NCT04214392. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CD5-deleted Chimeric Antigen Receptor Cells (Senza5 CART5) for T Cell Non-Hodgkin Lymphoma (NHL)
ClinicalTrials.gov study NCT06420089. IPD Sharing: NO. Countries: 1. Publications: 0.
Study to Assess Allogeneic Anti-CD38 A2 Dimeric Antigen Receptor T Cells in Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05007418. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anti-CD19/CD22 Bispecific Chimeric Antigen Receptor（CAR)-T Cell Therapy for Measurable Residual Disease(MRD) Positive ALL
ClinicalTrials.gov study NCT03919526. IPD Sharing: NO. Countries: 1. Publications: 0.
IL1RAP-targeting Chimeric Antigen Receptor T Cells in the Treatment of Relapsed/Refractory Hepatocellular Carcinoma
ClinicalTrials.gov study NCT06757881. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of the Expression of Met Receptor Fragments in Non Small Cell Lung Cancers
ClinicalTrials.gov study NCT01647867. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1
ClinicalTrials.gov study NCT06083883. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anti-CD19 Chimeric Antigen Receptor Modified T-cell (CAR-T) Therapy for Treatment of B-cell Hematological Malignancies
ClinicalTrials.gov study NCT06462248. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase 1 Study of JV-213 Autologous CD79b-targeting Chimeric Antigen Receptor T-cell Therapy in Adults With Relapsed or Refractory B-cell Lymphomas
ClinicalTrials.gov study NCT05773040. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Chimeric Antigen Receptor T-Cell (CAR-T) Cells in Patients With R/R T-LBL
ClinicalTrials.gov study NCT05554575. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
4th Generation Chimeric Antigen Receptor T Cells Targeting Glypican-3
ClinicalTrials.gov study NCT03980288. IPD Sharing: NO. Countries: 1. Publications: 0.
A Long-Term Follow-Up Basket Study for Participants Treated With SynKIR Chimeric Antigen Receptor (CAR) T Cell Product
ClinicalTrials.gov study NCT06701201. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of CAR-BCMA, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against BCMA in Subjects With Multiple Myeloma
ClinicalTrials.gov study NCT05243212. IPD Sharing: Not stated. Countries: 1. Publications: 0.
B-Cell Activating Factor Receptor (BAFFR)-Based Chimeric Antigen Receptor T-Cells With Fludarabine and Cyclophosphamide Lymphodepletion for the Treatment of Relapsed or Refractory B-cell Hematologic M
ClinicalTrials.gov study NCT06191887. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of CC-98633, BCMA-targeted Chimeric Antigen Receptor (CAR) T Cells, in Participants With Relapsed and/or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04394650. IPD Sharing: YES. Countries: 1. Publications: 0.
Exploratory Study of CD19-targeted Chimeric Antigen Receptor T Cells(BZ019) for Relapsed and Refractory B-cell Lymphoma
ClinicalTrials.gov study NCT04067414. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.